[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Saturday, 2 June 2007, 06:49 GMT 07:49 UK
Fake cancer drugs probe launched
Generic shot of pills being manufactured
The pills concerned carry the batch number 65520
A criminal investigation has been launched after a counterfeit batch of drugs used in the treatment of prostate cancer was discovered.

The batch claiming to be of the hormone treatment Casodex has been recalled.

The Medicines and Healthcare products Regulatory Agency (MHRA) said: "We take this very seriously and a criminal investigation is being carried out."

Patients whose medicine carries the batch number 65520 have been urged to contact their pharmacist.

'Great concern'

The MHRA, which oversees the regulation of medicines, said it had been contacted by a wholesaler who had been offered a suspicious batch of the medicine.

Tests showed the batch medicine contained only 75% of the amount of the active ingredient bicalutamide shown on the label.

"At present there is no evidence of patients having any adverse reactions specifically related to the counterfeits," the MHRA said in a statement.

Casodex is produced by the pharmaceutical company AstraZeneca.

Dr Chris Hiley, head of policy and research at The Prostate Cancer Charity, said: "This is the first time we have heard of counterfeit supplies of a well known prostate cancer treatment arriving and, possibly, being dispensed in the UK through the 'legitimate' supply chain.

"This is clearly of great concern. The wholesaler who alerted the MHRA should be commended.

"We have to wait and see how many of the batch are located and whether in fact men have taken any of them and, if so, for how long."


SEE ALSO

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites



FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

PRODUCTS & SERVICES

Americas Africa Europe Middle East South Asia Asia Pacific